Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Izopet

Showing results (1-10 of 498) with videos related to

Pageof 50
Sort By:
Hepatology (Baltimore, Md.)|November 12, 2013
Does chronic hepatitis E virus infection exist in immunocompetent patients?Nassim Kamar, Jacques Izopet
Medecine Sciences : M/S|January 1, 2009
[Hepatitis E: from zoonotic transmission to chronic infection in immunosuppressed patients]Jacques Izopet, Nassim Kamar
Cold Spring Harbor Perspectives in Medicine|March 14, 2018
Transmission and Epidemiology of Hepatitis E Virus Genotype 3 and 4 InfectionsHarry R Dalton, Jacques Izopet
Medecine Sciences : M/S|July 17, 2007
[A new system for the culture of hepatitis C virus]Florence Legrand-Abravanel, Jacques Izopet
Current Opinion in Gastroenterology|March 20, 2013
Hepatitis E virus infectionNassim Kamar, Jacques Izopet, Lionel Rostaing
The Journal of Infection|July 25, 2022
Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatmentCamille Vellas, Nassim Kamar, Jacques Izopet
Current Opinion in HIV and AIDS|July 27, 2012
Phenotyping methods for determining HIV tropism and applications in clinical settingsStéphanie Raymond, Pierre Delobel, Jacques Izopet
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 14, 2024
Which Hepatitis E virus to worry about in our transplant patientsOlivier Marion, Jacques Izopet, Nassim Kamar
The Journal of Antimicrobial Chemotherapy|June 18, 2010
Comment on: High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonistsStéphanie Raymond, Pierre Delobel, Jacques Izopet
Seminars in Liver Disease|April 9, 2013
Hepatitis E virus infection in immunosuppressed patients: natural history and therapyNassim Kamar, Lionel Rostaing, Jacques Izopet
Pageof 50

Showing results (1-10 of 498) with videos related to

Sort By:
Pageof 50
Hepatology (Baltimore, Md.)|November 12, 2013
Does chronic hepatitis E virus infection exist in immunocompetent patients?Nassim Kamar, Jacques Izopet
Medecine Sciences : M/S|January 1, 2009
[Hepatitis E: from zoonotic transmission to chronic infection in immunosuppressed patients]Jacques Izopet, Nassim Kamar
Cold Spring Harbor Perspectives in Medicine|March 14, 2018
Transmission and Epidemiology of Hepatitis E Virus Genotype 3 and 4 InfectionsHarry R Dalton, Jacques Izopet
Medecine Sciences : M/S|July 17, 2007
[A new system for the culture of hepatitis C virus]Florence Legrand-Abravanel, Jacques Izopet
Current Opinion in Gastroenterology|March 20, 2013
Hepatitis E virus infectionNassim Kamar, Jacques Izopet, Lionel Rostaing
The Journal of Infection|July 25, 2022
Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatmentCamille Vellas, Nassim Kamar, Jacques Izopet
Current Opinion in HIV and AIDS|July 27, 2012
Phenotyping methods for determining HIV tropism and applications in clinical settingsStéphanie Raymond, Pierre Delobel, Jacques Izopet
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 14, 2024
Which Hepatitis E virus to worry about in our transplant patientsOlivier Marion, Jacques Izopet, Nassim Kamar
The Journal of Antimicrobial Chemotherapy|June 18, 2010
Comment on: High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonistsStéphanie Raymond, Pierre Delobel, Jacques Izopet
Seminars in Liver Disease|April 9, 2013
Hepatitis E virus infection in immunosuppressed patients: natural history and therapyNassim Kamar, Lionel Rostaing, Jacques Izopet
Pageof 50